Fortunately, the biotech pipeline isstrong. Today biotech representsmore than 80 percent of the drugscurrently in development. Howto get those products through thepipeline faster, and to the HCPsand patients? That’s what’s on theminds of companies, organizations, laboratories and regulatorsright now.
Investment continues to grow innovel therapies, their mechanismsand platforms, and their potentialindications. Barriers are comingdown for products such as bio-similars and cell therapies. Thereis a global effort to make it easierfor patients to participate in trials,
TOP 50 BIOTECH COMPANIES
As is evidenced by much of the commentary in this issue, as well as in the news today,
biotech is more front and center than it ever was, given the challenges of containing
Covid- 19. It’s not just that disease itself that must be faced, but the many other
conditions that put patients at greater risk and vulnerability.
to speed up the trials, and to get toapproval. Obviously, we imaginethat we will be looking at a verydifferent landscape in 2020 as wesee the impact of Covid- 19. Just inthe area of a search for a coronavirus vaccine, we might see companies like Inovio, Novavax, HeatBiologics, BioNTech, Vaxart, VirBiotechnology, Moderna Therapeutics, Dynavax, Geovax andCurevac join the list if they are theones to find a solution.
For the moment, here are the latest
statistics on the ups and downs in
the biotech sector. Revenues grew
in 37 of the 50 with total revenues
of $326 billion. The Top 10 still
make up over 70% with their
portion of the revenue pie drop-
ping only 1% to 72% from 73%
in the year prior. Companies are
ranked by their 2019 revenue as
furnished by their annual reports
and publicly available sources such
as Edgar and Morningstar stock
information websites and Sec.gov.
Figures of non-U.S. companies
were converted to U.S. dollars
from various currencies using end
of the year exchange rates for 2019.
Companies are categorized by
their predominant revenue source
and their own characterization per
publicly available sources.
CLICK HERE TO GET
TOP 50 BIOTECH